Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients

Rheumatology (United Kingdom)

Volumn 51, Issue 10, 2012, Pages 1775-1784

  Rodríguez Carrio, Javier ^a   Prado, Catuxa ^a   De paz, Banesa ^a   López, Patricia ^a   Gómez, Jesús ^b   Alperi López, Mercedes ^c   Ballina García, Francisco J ^c   Suárez, Ana ^a  

^a UNIVERSITY OF OVIEDO   (Spain)

^b Department of Immunology ^*  (Spain)

^c HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

Author keywords

Autoantibodies; Endothelial progenitor cells; Interferon ; Rheumatoid arthritis; Systemic lupus erythematosus; Vascular damage

Indexed keywords

ALPHA INTERFERON; BIOLOGICAL MARKER; CD133 ANTIGEN; CD34 ANTIGEN; CYTOKINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 2;

ADULT; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CELL COUNT; CELL POPULATION; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIAL PROGENITOR CELL; ENDOTHELIUM CELL; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOASSAY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; STATISTICAL SIGNIFICANCE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADULT; ARTHRITIS, RHEUMATOID; CYTOKINES; ENDOTHELIAL CELLS; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; STEM CELLS;

EID: 84867116092     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kes152     Document Type: Article

References (50)

1. Esdaile JM, Abrahamowicz M, Grodzicky T et al. Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus. Arthritis Rheum 2001;44:2331-7.
2. Bartoloni E, Shoenfeld Y, Gerli R. Inflammatory and autoimmune mechanisms in the induction of atherosclerotic damage in systemic rheumatic diseases: two faces of the same coin. Arthritis Care Res 2011;63:178-83.
3. Avouac J, Uzan G, Kahan A, Boileau C, Allanore Y. Endothelial progenitor cells and rheumatic disorders. Joint Bone Spine 2008;75:131-7.
4. Asahara T, Murohara T, Sullivan A et al. Isolation of putative progenitor endothelial cells for angiogenesis. Science 1997;275:964-7.
5. Hristov M, Erl W, Weber PC. Endothelial progenitor cells: isolation and characterization. Trends Cardiovasc Med 2003;13:201-6.
6. Takahashi M, Izawa A, Ishigatsubo Y et al. Therapeutic neovascularization by the implantation of autologous mononuclear cells in patients with connective tissue diseases. Curr Pharm Des 2009;15:2778-83.
7. Hill JM, Zalos G, Halcox JP et al. Circulating endothelial progenitor cells, vascular function, and cardiovascular risk. N Engl J Med 2003;348:593-600.
8. Werner N, Kosiol S, Schiegl T et al. Circulating endothelial progenitor cells and cardiovascular outcomes. N Engl J Med 2005;353:999-1007.
9. Deng XL, Li XX, Liu XY, Sun L, Liu R. Comparative study on circulating endothelial progenitor cells in systemic lupus erythematosus patients at active stage. Rheumatol Int 2010;30:1429-36.
10. Denny MF, Thacker S, Mehta H et al. Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis. Blood 2007;110: 2907-15.
11. Lee PY, Li Y, Richards HB et al. Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis Rheum 2007;56:3759-69.
12. Moonen JR, de LK, van Seijen XJ et al. Reduced number and impaired function of circulating progenitor cells in patients with systemic lupus erythematosus. Arthritis Res Ther 2007;9:R84.
13. Westerweel PE, Luijten RK, Hoefer IE et al. Haematopoietic and endothelial progenitor cells are deficient in quiescent systemic lupus erythematosus. Ann Rheum Dis 2007;66:865-70.
14. Grisar J, Aletaha D, Steiner CW et al. Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritis. Circulation 2005;111:204-11.
15. Herbrig K, Haensel S, Oelschlaegel U et al. Endothelial dysfunction in patients with rheumatoid arthritis is associated with a reduced number and impaired function of endothelial progenitor cells. Ann Rheum Dis 2006;65: 157-63.
16. Jodon de Villeroché V, Avouac J, Ponceau A et al. Enhanced late-outgrowth circulating endothelial progenitor cell levels in rheumatoid arthritis and correlation with disease activity. Arthritis Res Ther 2010;12:R27.
17. Robak E, Kierstan M, Cebula B et al. Circulating endothelial cells and angiogenic proteins in patients with systemic lupus erythematosus. Lupus 2009;18:332-41.
18. Grisar J, Steiner CW, Bonelli M et al. Systemic lupus erythematosus patients exhibit functional deficiencies of endothelial progenitor cells. Rheumatology 2008;47: 1476-83.
19. Ablin JN, Boguslavski V, Aloush V et al. Enhanced adhesive properties of endothelial progenitor cells (EPCs) in patients with SLE. Rheumatol Int 2011;31:773-8.
20. Rajagopalan S, Somers EC, Brook RD et al. Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensity. Blood 2004;103:3677-83.
21. Westerweel PE, Verhaar MC. Endothelial progenitor cell dysfunction in rheumatic disease. Nat Rev Rheumatol 2009;5:332-40.
22. Frostegard J. Atherosclerosis in patients with autoimmune disorders. Arterioscler Thromb Vasc Biol 2005;25: 1776-85.
23. Lopez P, Mozo L, Gutierrez C, Suarez A. Epidemiology of systemic lupus erythematosus in a northern Spanish population: gender and age influence on immunological features. Lupus 2003;12:860-5.
24. Distler JH, Allanore Y, Avouac J et al. EULAR Scleroderma Trials and Research group statement and recommendations on endothelial precursor cells. Ann Rheum Dis 2009; 68:163-8.
25. Peichev M, Naiyer AJ, Pereira D et al. Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 2000;95:952-8.
26. Abramson SB, Amin AR, Clancy RM, Attur M. The role of nitric oxide in tissue destruction. Best Pract Res Clin Rheumatol 2001;15:831-45.
27. Clancy R, Marder G, Martin V et al. Circulating activated endothelial cells in systemic lupus erythematosus: further evidence for diffuse vasculopathy. Arthritis Rheum 2001; 44:1203-8.
28. Khakoo AY, Finkel T. Endothelial progenitor cells. Annu Rev Med 2005;56:79-101.
29. Elshal M, Abdelaziz A, Abbas A et al. Quantification of circulating endothelial cells in peripheral blood of systemic lupus erythematosus patients: a simple and reproducible method of assessing endothelial injury and repair. Nephrol Dial Transplant 2009;24:1495-9.
30. Thacker SG, Duquaine D, Park J, Kaplan MJ. Lupus-prone New Zealand Black/New Zealand White F1 mice display endothelial dysfunction and abnormal phenotype and function of endothelial progenitor cells. Lupus 2010;19: 288-99.
31. Vaudo G, Bocci EB, Shoenfeld Y et al. Precocious intima-media thickening in patients with primary Sjogren's syndrome. Arthritis Rheum 2005;52:3890-7.
32. Egan CG, Caporali F, Garcia-Gonzalez E, Galeazzi M, Sorrentino V. Endothelial progenitor cells and colony-forming units in rheumatoid arthritis: association with clinical characteristics. Rheumatology 2008;47: 1484-8.
33. Friedrich EB, Walenta K, Scharlau J, Nickenig G, Werner N. CD34-/CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 2006;98:e20-5.
34. Allanore Y, Batteux F, Avouac J et al. Levels of circulating endothelial progenitor cells in systemic sclerosis. Clin Exp Rheumatol 2007;25:60-6.
35. Avouac J, Juin F, Wipff J et al. Circulating endothelial progenitor cells in systemic sclerosis: association with disease severity. Ann Rheum Dis 2008;67:1455-60.
36. de Groot K, Goldberg C, Bahlmann FH et al. Vascular endothelial damage and repair in antineutrophil cytoplasmic antibody-associated vasculitis. Arthritis Rheum 2007; 56:3847-53.
37. George J, Shmilovich H, Deutsch V et al. Comparative analysis of methods for assessment of circulating endothelial progenitor cells. Tissue Eng 2006;12:331-5.
38. Magro CM, Crowson AN. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. Am J Dermatopathol 1999;21:129-37.
39. Thompson D, Juby A, Davis P. The clinical significance of autoantibody profiles in patients with systemic lupus erythematosus. Lupus 1993;2:15-9.
40. Kahlenberg JM, Thacker SG, Berthier CC et al. Inflammasome activation of IL-18 results in endothelial progenitor cell dysfunction in systemic lupus erythematosus. J Immunol 2011;187:6143-56.
41. Lood C, Amisten S, Gullstrand B et al. Platelet transcriptional profile and protein expression in patients with systemic lupus erythematosus: up-regulation of the type I interferon system is strongly associated with vascular disease. Blood 2010;116:1951-7.
42. Tabas I. Macrophage death and defective inflammation resolution in atherosclerosis. Nat Rev Immunol 2010;10: 36-46.
43. Thacker SG, Berthier CC, Mattinzoli D et al. The detrimental effects of IFN-alpha on vasculogenesis in lupus are mediated by repression of IL-1 pathways: potential role in atherogenesis and renal vascular rarefaction. J Immunol 2010;185:4457-69.
44. Asanuma Y, Chung CP, Oeser A et al. Increased concentration of proatherogenic inflammatory cytokines in systemic lupus erythematosus: relationship to cardiovascular risk factors. J Rheumatol 2006;33:539-45.
45. Rho YH, Chung CP, Oeser A et al. Inflammatory mediators and premature coronary atherosclerosis in rheumatoid arthritis. Arthritis Rheum 2009;61:1580-5.
46. Bernardini G, Ribatti D, Spinetti G et al. Analysis of the role of chemokines in angiogenesis. J Immunol Methods 2003; 273:83-101.
47. O'Neill TJ, Wamhoff BR, Owens GK, Skalak TC. Mobilization of bone marrow-derived cells enhances the angiogenic response to hypoxia without transdifferentiation into endothelial cells. Circ Res 2005;97:1027-35.
48. Moran EM, Connolly M, Gao W et al. Interleukin-17A induction of angiogenesis, cell migration, and cytoskeletal rearrangement. Arthritis Rheum 2011;63: 3263-73.
49. Gerli R, Bartoloni BE, Sherer Y et al. Association of anti-cyclic citrullinated peptide antibodies with subclinical atherosclerosis in patients with rheumatoid arthritis. Ann Rheum Dis 2008;67:724-5.
50. Woywodt A, Goldberg C, Scheer J et al. An improved assay for enumeration of circulating endothelial cells. Ann Hematol 2004;83:491-4.